Asset Details
Do you wish to reserve the book?
Molecular Features and Clinical Management of Hereditary Gynecological Cancers
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Molecular Features and Clinical Management of Hereditary Gynecological Cancers
Do you wish to request the book?
Molecular Features and Clinical Management of Hereditary Gynecological Cancers
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Molecular Features and Clinical Management of Hereditary Gynecological Cancers
2020
Overview
Hereditary gynecological cancers are caused by several inherited genes. Tumors that arise in the female reproductive system, such as ovaries and the uterus, overlap with hereditary cancers. Several hereditary cancer-related genes are important because they might lead to therapeutic targets. Treatment of hereditary cancers should be updated in line with the advent of various new methods of evaluation. Next-generation sequencing has led to rapid, economical genetic analyses that have prompted a concomitant and significant paradigm shift with respect to hereditary cancers. Molecular tumor profiling is an epochal method for determining therapeutic targets. Clinical treatment strategies are now being designed based on biomarkers based on tumor profiling. Furthermore, the National Comprehensive Cancer Network (NCCN) guidelines significantly changed the genetic testing process in 2020 to initially consider multi-gene panel (MGP) evaluation. Here, we reviewed the molecular features and clinical management of hereditary gynecological malignancies, such as hereditary breast and ovarian cancer (HBOC), and Lynch, Li–Fraumeni, Cowden, and Peutz–Jeghers syndromes. We also reviewed cancer-susceptible genes revealed by MGP tests.
Publisher
MDPI AG,MDPI
Subject
/ Breast Neoplasms - metabolism
/ Breast Neoplasms - pathology
/ Colorectal Neoplasms, Hereditary Nonpolyposis - genetics
/ Colorectal Neoplasms, Hereditary Nonpolyposis - metabolism
/ Colorectal Neoplasms, Hereditary Nonpolyposis - pathology
/ DNA
/ Female
/ Genes
/ Genetic Predisposition to Disease - genetics
/ Hereditary Breast and Ovarian Cancer Syndrome - genetics
/ Hereditary Breast and Ovarian Cancer Syndrome - metabolism
/ Hereditary Breast and Ovarian Cancer Syndrome - pathology
/ High-Throughput Nucleotide Sequencing
/ Humans
/ Mutation
/ Review
/ Tumors
